Nevirapine (200mg) + Lamivudine (150mg) + Stavudine (30mg), in this combination Nevirapine (NVP) is a non-nucleoside transcriptase inhibitor and the other two medicines Lamivudine and Stavudine are nucleoside reverse transcriptase inhibitors.
This combination has optimal efficacy, and durability of antiretroviral activity and is used as first line therapy specially in low resource countries. It is phosphorylated in the body to the active triphosphate form.
It is easily tolerable and has low adverse effects while in drug to drug interactions.
It inhibits Hepatitis B virus polymerase and HIV reverse transcriptase enzymes.
The combination decreases the amount of HIV in blood and treats/prevents the effects of AIDS in the body.
It strengthens the immune system to fight the viruses and infections in the body.
The combo avoids the multiplication of the cells and production of new cells.
Do not skip or overlap the doses, maintain proper interval time between two doses.
Discontinuation of the tablet course even if you feel better might delay the treatment and reverse the disease, therefore do not stop taking the tablet unless your doctor suggests you to stop.
Tell your doctor about your medical history of liver, kidney, heart or any health issues and the medications that you are already on.
Talk to your doctor about all the risks, after effects before you start using the medicine.
Pregnant women, women planning for pregnancy, breast feeding mothers should not take the medicine, talk to your doctor if it is an unavoidable situation.